Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
CG Oncology, Inc. ( (CGON) ) has provided an update.
CG Oncology, Inc. has entered into amended and restated employment agreements with its top executives including the CEO, President, and other key officers. These agreements outline severance benefits applicable during and outside of a change in control period, impacting the company’s operational stability and providing financial security to its executives in the event of termination without cause.
More about CG Oncology, Inc.
YTD Price Performance: 5.14%
Average Trading Volume: 634,140
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $2.32B
See more insights into CGON stock on TipRanks’ Stock Analysis page.
